These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 25454365

  • 1. [Benefits in reducing alcohol consumption: how nalmefene can help].
    Bendimerad P, Blecha L.
    Encephale; 2014 Dec; 40(6):495-500. PubMed ID: 25454365
    [Abstract] [Full Text] [Related]

  • 2. Nalmefene. Alcohol dependence: no advance.
    Prescrire Int; 2014 Jun; 23(150):150-2. PubMed ID: 25121147
    [Abstract] [Full Text] [Related]

  • 3. Comparing Nalmefene and Naltrexone in Alcohol Dependence: Are there any Differences? Results from an Indirect Meta-Analysis.
    Soyka M, Friede M, Schnitker J.
    Pharmacopsychiatry; 2016 Mar; 49(2):66-75. PubMed ID: 26845589
    [Abstract] [Full Text] [Related]

  • 4. Nalmefene for Reducing Alcohol Consumption in People with Alcohol Dependence: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
    Stevenson M, Pandor A, Stevens JW, Rawdin A, Rice P, Thompson J, Morgan MY.
    Pharmacoeconomics; 2015 Aug; 33(8):833-47. PubMed ID: 25851485
    [Abstract] [Full Text] [Related]

  • 5. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
    Karhuvaara S, Simojoki K, Virta A, Rosberg M, Löyttyniemi E, Nurminen T, Kallio A, Mäkelä R.
    Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
    [Abstract] [Full Text] [Related]

  • 6. A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence.
    Gual A, He Y, Torup L, van den Brink W, Mann K, ESENSE 2 Study Group.
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1432-42. PubMed ID: 23562264
    [Abstract] [Full Text] [Related]

  • 7. The Effects of as-Needed Nalmefene on Patient-Reported Outcomes and Quality of Life in Relation to a Reduction in Alcohol Consumption in Alcohol-Dependent Patients.
    François C, Rahhali N, Chalem Y, Sørensen P, Luquiens A, Aubin HJ.
    PLoS One; 2015 Nov; 10(6):e0129289. PubMed ID: 26053024
    [Abstract] [Full Text] [Related]

  • 8. Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene.
    Mann K, Bladström A, Torup L, Gual A, van den Brink W.
    Biol Psychiatry; 2013 Apr 15; 73(8):706-13. PubMed ID: 23237314
    [Abstract] [Full Text] [Related]

  • 9. The Cost Effectiveness of Nalmefene for Reduction of Alcohol Consumption in Alcohol-Dependent Patients with High or Very High Drinking-Risk Levels from a UK Societal Perspective.
    Brodtkorb TH, Bell M, Irving AH, Laramée P.
    CNS Drugs; 2016 Feb 15; 30(2):163-77. PubMed ID: 26879458
    [Abstract] [Full Text] [Related]

  • 10. Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials.
    Palpacuer C, Laviolle B, Boussageon R, Reymann JM, Bellissant E, Naudet F.
    PLoS Med; 2015 Dec 15; 12(12):e1001924. PubMed ID: 26694529
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Pharmacological profile and clinical findings of nalmefene (Selincro®) for reducing alcohol consumption in patients with alcohol dependence].
    Tadori Y.
    Nihon Yakurigaku Zasshi; 2020 Dec 15; 155(2):113-119. PubMed ID: 32115477
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Opioid Receptor Antagonists in the Treatment of Alcoholism.
    Serecigni JG.
    Adicciones; 2015 Sep 29; 27(3):214-30. PubMed ID: 26437315
    [Abstract] [Full Text] [Related]

  • 15. Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled study.
    van den Brink W, Sørensen P, Torup L, Mann K, Gual A, SENSE Study Group.
    J Psychopharmacol; 2014 Aug 29; 28(8):733-44. PubMed ID: 24671340
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.